IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

John B. Mumm; Jan Emmerich; Xueqing Zhang; Ivan H. Chan; Lingling Wu; Smita Mauze; Steven Blaisdell; Beth Basham; Jie Dai; Jeff Grein; Catherine Sheppard; Kyu Hong; Collette Cutler; Scott Turner; Drake LaFace; Melanie A. Kleinschek; Michael Judo; Gulesi Ayanoglu; John L. Langowski; Danling Gu; Brittany Paporello; Erin Murphy; Venkataraman Sriram; Saraswathi Naravula; Bela Desai; Satya Medicherla; Wolfgang Seghezzi; Terrill K. McClanahan; Susan Cannon‐Carlson; Amy M. Beebe; Martin Oft

doi:10.1016/j.ccr.2011.11.003

IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

John B. Mumm(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jan Emmerich(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xueqing Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ivan H. Chan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lingling Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Smita Mauze(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven Blaisdell(Merck & Co., Inc., Rahway, NJ, USA (United States)), Beth Basham(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jie Dai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeff Grein(Merck & Co., Inc., Rahway, NJ, USA (United States)), Catherine Sheppard(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kyu Hong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Collette Cutler(Merck & Co., Inc., Rahway, NJ, USA (United States)), Scott Turner(Merck & Co., Inc., Rahway, NJ, USA (United States)), Drake LaFace(Merck & Co., Inc., Rahway, NJ, USA (United States)), Melanie A. Kleinschek(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael Judo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gulesi Ayanoglu(Merck & Co., Inc., Rahway, NJ, USA (United States)), John L. Langowski(Merck & Co., Inc., Rahway, NJ, USA (United States)), Danling Gu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Brittany Paporello(Merck & Co., Inc., Rahway, NJ, USA (United States)), Erin Murphy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Venkataraman Sriram(Merck & Co., Inc., Rahway, NJ, USA (United States)), Saraswathi Naravula(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bela Desai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Satya Medicherla(Merck & Co., Inc., Rahway, NJ, USA (United States)), Wolfgang Seghezzi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Terrill K. McClanahan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Susan Cannon‐Carlson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amy M. Beebe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Martin Oft(Merck & Co., Inc., Rahway, NJ, USA (United States))

Cancer Cell

December 1, 2011

10.1016/j.ccr.2011.11.003

Cited by 412Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis